Breast cancer cell lines with a wild-type or mutated PIK3CA gene were also assayed, and the IC50 values, in the low micromolar range, were similar to those previously reported for the CH5132799 drug (PA-799) (19). Here, PIK3CA is linked to breast carcinoma.